Levamisole, an anthelmintic and immunomodulatory drug, was withdrawn from the US market in 1999 due to adverse effects, including agranulocytosis and vasculitis. In recent years, levamisole has been used as a common cocaine adulterant, and its use has led to an autoimmune syndrome characterized by an antineutrophil cytoplasmic antibody-associated vasculitis presenting with necrotic retiform purpura on the face and extremities. We present a case of recurrent levamisole-induced vasculitis initially misdiagnosed as systemic lupus erythematosus to highlight this easily misdiagnosed entity and to demonstrate re-exposure leading to recurrent vasculitis with more extensive clinical manifestations.

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000001837DOI Listing

Publication Analysis

Top Keywords

antineutrophil cytoplasmic
8
cytoplasmic antibody-associated
8
antibody-associated vasculitis
8
vasculitis
5
recurrent antineutrophil
4
vasculitis induced
4
induced levamisole-adulterated
4
levamisole-adulterated cocaine
4
cocaine levamisole
4
levamisole anthelmintic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!